Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells
- PMID: 12115645
- DOI: 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q
Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells
Abstract
Anergic/suppressive CD4+CD25+ T cells have been proposed to play an important role in the maintenance of peripheral tolerance. Here we demonstrate that in humans these cells suppress proliferation to self antigens, but also to dietary and foreign antigens. The suppressive CD4+CD25+ T cells display a broad usage of the T cell receptor Vbeta repertoire,suggesting that they recognize a wide variety of antigens. They reside in the primed/memory CD4+CD45RO+CD45RB(low) subset and have short telomeres, indicating that these cells have the phenotype of highly differentiated CD4+ T cells that have experienced repeated episodes of antigen-specific stimulation in vivo. This suggests that anergic/suppressive CD4+CD25+ T cells may be generated in the periphery as a consequence of repeated antigenic encounter. This is supported by the observation that highly differentiated CD4+T cells can be induced to become anergic/suppressive when stimulated by antigen presented by non-professional antigen-presenting cells. We suggest that besides being generated in the thymus, CD4+CD25+ regulatory T cells may also be generated in the periphery. This would provide a mechanism for the generation of regulatory cells that induce tolerance to a wide array of antigens that may not be encountered in the thymus.
Similar articles
-
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.J Exp Med. 2003 Dec 15;198(12):1875-86. doi: 10.1084/jem.20030152. J Exp Med. 2003. PMID: 14676299 Free PMC article.
-
Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.J Clin Invest. 2006 Sep;116(9):2423-33. doi: 10.1172/JCI28941. J Clin Invest. 2006. PMID: 16955142 Free PMC article.
-
Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.Semin Immunol. 2004 Apr;16(2):135-43. doi: 10.1016/j.smim.2003.12.009. Semin Immunol. 2004. PMID: 15036237 Review.
-
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.Cancer. 2003 Sep 1;98(5):1089-99. doi: 10.1002/cncr.11618. Cancer. 2003. PMID: 12942579
-
Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.Novartis Found Symp. 2003;252:115-27; discussion 127-31, 203-10. Novartis Found Symp. 2003. PMID: 14609215 Review.
Cited by
-
Effects of telbivudine treatment on the circulating CD4⁺ T-cell subpopulations in chronic hepatitis B patients.Mediators Inflamm. 2012;2012:789859. doi: 10.1155/2012/789859. Epub 2012 Apr 11. Mediators Inflamm. 2012. PMID: 22570512 Free PMC article.
-
Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells.Hum Immunol. 2005 Mar;66(3):222-30. doi: 10.1016/j.humimm.2004.12.006. Hum Immunol. 2005. PMID: 15784460 Free PMC article.
-
FOXP3+ regulatory T cells in the human immune system.Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18. Nat Rev Immunol. 2010. PMID: 20559327 Review.
-
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.PLoS Biol. 2004 Jul;2(7):E198. doi: 10.1371/journal.pbio.0020198. Epub 2004 Jul 13. PLoS Biol. 2004. PMID: 15252446 Free PMC article.
-
High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets.Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1518-23. doi: 10.1073/pnas.0913939107. Epub 2010 Jan 4. Proc Natl Acad Sci U S A. 2010. PMID: 20080641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials